MONDAY, Dec. 20, 2021 (HealthDay News) — French Bulldogs are incredibly cute, sporting adorable snub snouts, big round heads, bright wide eyes and large bat ears. Unfortunately, the physical traits that make them one of the most popular breeds in the United States and United Kingdom also saddle them withContinue Reading

SUNDAY, Dec. 19, 2021 (HealthDay News) — If you’re among the many people who use space heaters and generators during the winter, you need to guard against fire and carbon monoxide (CO) hazards, the U.S. Consumer Product Safety Commission (CPSC) says. In the United States, that’s especially true for BlackContinue Reading

WEDNESDAY, Dec. 15, 2021 (HealthDay News) — “Medicare For All” gets tossed around a lot by advocates of universal health coverage, but a new study finds that today’s Medicare is far from free for seniors and people with disabilities. Instead, a large number of beneficiaries are sliding into medical debtContinue Reading

WEDNESDAY, Dec. 15, 2021 (HealthDay News) — Here’s a social distancing strategy that really worked in the early days of the pandemic: New research shows that providing hotel rooms to homeless people at high risk for severe COVID-19 significantly lowered their chance of infection. In early April 2020, the cityContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — Big “surprise” medical bills may still be a problem for Americans. According to a new study, more than half of U.S. hospitals haven’t complied with recent regulations requiring that they disclose their prices online for all services, to help prevent unexpected bills forContinue Reading

MONDAY, Dec. 13, 2021 (HealthDay News) — You can’t always choose who operates on you, especially in an emergency, but the sex of your surgeon shouldn’t matter, should it? It just may, according to a Canadian study of 1.3 million people. It reported that women who underwent common elective orContinue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based onContinue Reading